Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a backend/metadata change. There is no indication of changes to the visible content or layout.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s footer revision label has been updated from **v3.5.2** to **v3.5.3**, reflecting a minor update to the site software/display version without altering the underlying study record details.SummaryDifference0.0%

- Check40 days agoChange DetectedCurrent revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded medullary thyroid carcinoma to the conditions list and included Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check76 days agoChange DetectedSite updated from version 3.4.2 to 3.4.3; no changes to study content or user-facing functionality are evident.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.